NCT03228433View on ClinicalTrials.gov

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Oral Single Dose of TAK-418 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 21, 2017

Primary Completion Date

May 12, 2018

Study Completion Date

May 12, 2018

Conditions
Healthy Participants
Interventions
DRUG

TAK-418

TAK-418 Capsule.

DRUG

TAK-418 Placebo

TAK-418 placebo-matching capsules.

Trial Locations (1)

91206

PAREXEL International, Glendale

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY